Health & Wellness
Los Angeles, CA. - A long-term feeding study commissioned by the Austrian Agency for Health and Food Safety, managed by the Austrian Federal Ministry of Health, Family and Youth, and carried out by Veterinary University Vienna, confirms genetically modified (GM) corn seriously affects reproductive health in mice. Non-GMO advocates, who have warned about this infertility link along with other health risks, now seek an immediate ban of all GM foods and GM crops to protect the health of humankind and the fertility of women around the world.
Feeding mice with genetically modified corn developed by the US-based Monsanto Corporation led to lower fertility and body weight, according to the study conducted by the University of Veterinary Medicine in Vienna. Lead author of the study Professor Zentek said, there was a direct link between the decrease in fertility and the GM diet, and that mice fed with non-GE corn reproduced more efficiently.
In the study, Austrian scientists performed several long-term feeding trials over 20 weeks with laboratory mice fed a diet containing 33% of a GM variety (NK 603 x MON 810), or a closely related non-GE variety used in many countries. Statistically significant litter size and pup weight decreases were found in the third and fourth litters in the GM-fed mice, compared to the control group.
But while the case has novel medical implications, experts say it will be of little immediate use in treating AIDS. Top American researchers called the treatment unthinkable for the millions infected in Africa and impractical even for insured patients in top research hospitals.
"It's very nice, and it's not even surprising," said Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases. "But it's just off the table of practicality."
The problems included facial palsy, disfigurement and "rare but life-threatening events such as severe allergic reactions and anaphylactic shock," the FDA staff said.
The agency said it received a total of 930 reports of health problems over the past six years. Many included known complications such as minor swelling. The FDA did not identify which products had reports of more serious problems.
The FDA staff said the reports had several limitations such as failing to say when the problems started.
Two top U.S. health officials announced they will go to China next week to open food inspection offices and talk about food safety after a series of health scares from Chinese-made food products.
Health and Human Services Secretary Mike Leavitt and Food and Drug Administration Commissioner Dr. Andrew von Eschenbach will also open new FDA offices in Beijing, Guangzhou and Shanghai.
The Gardasil vaccine was 90 percent effective in preventing lesions, mostly sexually transmitted warts, caused by the virus in men, Anna Giuliano of the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida, and colleagues found.
It was about 45 percent effective in preventing infection with the four strains of HPV that it targets.
The Flu Trends Web site will comb through search words, such as "cough" and "fever," entered by Google users who likely have the flu and use the data to compile a map showing the severity of flu in various regions.
Lyn Finelli, who heads the influenza surveillance team at the Centers for Disease Control in Atlanta, told The Wall Street Journal the real-time service "maps very closely to the influenza-like trends that we see in the United States."
The CFIA said Lucerne Foods, a division of Canada Safeway Ltd., is voluntarily recalling the product because it might contain egg proteins not declared on its label, thereby posing a health risk for people allergic to eggs.
Scientists from Copenhagen University Hospitals, led by Dr. Jacob Freiberg, said the methodology used in previous studies might have missed an association between triglycerides and ischemic stroke.
In a survey of some 7,500 people with chronic diseases in eight industrial nations, 54% of U.S. respondents said they had skimped on recommended care during the previous two years because of costs, reported Cathy Schoen, M.S., of the Commonwealth Fund here, and colleagues online in Health Affairs.
But the U.S. respondents were also much less likely than residents of other countries to report waiting two months or longer to see a specialist.




